{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:37:31Z","timestamp":1769387851099,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1038\/s41434-022-00336-3","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T08:04:04Z","timestamp":1652083444000},"page":"730-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["CRISPR\/Cas9-based genome editing for the modification of multiple duplications that cause Duchenne muscular dystrophy"],"prefix":"10.1038","volume":"29","author":[{"given":"Dan-Ni","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9655-9735","authenticated-orcid":false,"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"336_CR1","doi-asserted-by":"publisher","first-page":"18168","DOI":"10.3390\/molecules201018168","volume":"20","author":"MS Falzarano","year":"2015","unstructured":"Falzarano MS, Scotton C, Passarelli C, Ferlini A. Duchenne muscular dystrophy: from diagnosis to therapy. Molecules. 2015;20:18168\u201384.","journal-title":"Molecules."},{"key":"336_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, et al. The treat-nmd dmd global database: analysis of more than 7,000 duchenne muscular dystrophy mutations. Hum Mutat. 2015;36:395\u2013402.","journal-title":"Hum Mutat"},{"key":"336_CR3","doi-asserted-by":"crossref","unstructured":"Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of duchenne muscular dystrophy. Cochrane Database Syst Rev. 2016:CD003725.","DOI":"10.1002\/14651858.CD003725.pub4"},{"key":"336_CR4","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F. Development and applications of crispr-cas9 for genome engineering. Cell. 2014;157:1262\u201378.","journal-title":"Cell."},{"key":"336_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.tibtech.2020.10.012","volume":"39","author":"JH Goell","year":"2021","unstructured":"Goell JH, Hilton IB. Crispr\/cas-based epigenome editing: Advances, applications, and clinical utility. Trends Biotechnol. 2021;39:678\u201391.","journal-title":"Trends Biotechnol"},{"key":"336_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10561-004-7990-4","volume":"6","author":"ME Vazquez","year":"2005","unstructured":"Vazquez ME, Cabarcos MR, Roman TD, Stein AJ, Garcia ND, Nazar BA, et al. Cellular cardiomyoplasty: Development of a technique to culture human myoblasts for clinical transplantation. Cell Tissue Bank. 2005;6:117\u201324.","journal-title":"Cell Tissue Bank"},{"key":"336_CR7","doi-asserted-by":"publisher","first-page":"e51865","DOI":"10.1371\/journal.pone.0051865","volume":"7","author":"A Tassin","year":"2012","unstructured":"Tassin A, Leroy B, Laoudj-Chenivesse D, Wauters A, Vanderplanck C, Le Bihan MC, et al. Fshd myotubes with different phenotypes exhibit distinct proteomes. PLoS ONE. 2012;7:e51865.","journal-title":"PLoS ONE"},{"key":"336_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.jcyt.2013.05.014","volume":"15","author":"M Schumm","year":"2013","unstructured":"Schumm M, Lang P, Bethge W, Faul C, Feuchtinger T, Pfeiffer M, et al. Depletion of t-cell receptor alpha\/beta and cd19 positive cells from apheresis products with the clinimacs device. Cytotherapy. 2013;15:1253\u20138.","journal-title":"Cytotherapy."},{"key":"336_CR9","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1097\/01.ju.0000131944.52354.63","volume":"172","author":"H Suttmann","year":"2004","unstructured":"Suttmann H, Jacobsen M, Reiss K, Jocham D, Bohle A, Brandau S. Mechanisms of bacillus calmette-guerin mediated natural killer cell activation. J Urol. 2004;172:1490\u20135.","journal-title":"J Urol"},{"key":"336_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.omtn.2017.02.004","volume":"7","author":"A Lattanzi","year":"2017","unstructured":"Lattanzi A, Duguez S, Moiani A, Izmiryan A, Barbon E, Martin S, et al. Correction of the exon 2 duplication in dmd myoblasts by a single crispr\/cas9 system. Mol Ther Nucleic Acids. 2017;7:11\u20139.","journal-title":"Mol Ther Nucleic Acids"},{"key":"336_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7244","volume":"6","author":"DG Ousterout","year":"2015","unstructured":"Ousterout DG, Kabadi AM, Thakore PI, Majoros WH, Reddy TE, Gersbach CA. Multiplex crispr\/cas9-based genome editing for correction of dystrophin mutations that cause duchenne muscular dystrophy. Nat Commun. 2015;6:6244.","journal-title":"Nat Commun"},{"key":"336_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/mt.2015.192","volume":"24","author":"L Xu","year":"2016","unstructured":"Xu L, Park KH, Zhao L, Xu J, El Refaey M, Gao Y, et al. Crispr-mediated genome editing restores dystrophin expression and function in mdx mice. Mol Ther. 2016;24:564\u20139.","journal-title":"Mol Ther"},{"key":"336_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long C, Amoasii L, Mireault AA, McAnally JR, Li H, Sanchez-Ortiz E, et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science. 2016;351:400\u20133.","journal-title":"Science."},{"key":"336_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM, et al. In vivo genome editing improves muscle function in a mouse model of duchenne muscular dystrophy. Science. 2016;351:403\u20137.","journal-title":"Science."},{"key":"336_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar M, Zhu K, Cheng JKW, Chew WL, Widrick JJ, Yan WX, et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science. 2016;351:407\u201311.","journal-title":"Science."},{"key":"336_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addr.2015.05.008","volume":"87","author":"R Kole","year":"2015","unstructured":"Kole R, Krieg AM. Exon skipping therapy for duchenne muscular dystrophy. Adv Drug Deliv Rev. 2015;87:104\u20137.","journal-title":"Adv Drug Deliv Rev"},{"key":"336_CR17","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1038\/mtna.2014.8","volume":"3","author":"KL Greer","year":"2014","unstructured":"Greer KL, Lochmuller H, Flanigan K, Fletcher S, Wilton SD. Targeted exon skipping to correct exon duplications in the dystrophin gene. Mol Ther Nucleic Acids. 2014;3:e155.","journal-title":"Mol Ther Nucleic Acids"},{"key":"336_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0220-7","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Zhao L, Zhou S, Hu C, Shi Y, Shi W, et al. A comprehensive database of duchenne and becker muscular dystrophy patients (0\u201318 years old) in east China. Orphanet J Rare Dis. 2015;10:5.","journal-title":"Orphanet J Rare Dis"},{"key":"336_CR19","doi-asserted-by":"publisher","first-page":"572006","DOI":"10.3389\/fneur.2020.572006","volume":"11","author":"YR Tong","year":"2020","unstructured":"Tong YR, Geng C, Guan YZ, Zhao YH, Ren HT, Yao FX, et al. A comprehensive analysis of 2013 dystrophinopathies in china: A report from national rare disease center. Front Neurol. 2020;11:572006.","journal-title":"Front Neurol"},{"key":"336_CR20","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","volume":"560","author":"F Adikusuma","year":"2018","unstructured":"Adikusuma F, Piltz S, Corbett MA, Turvey M, McColl SR, Helbig KJ, et al. Large deletions induced by cas9 cleavage. Nature. 2018;560:E8\u2013E9.","journal-title":"Nature."},{"key":"336_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09006-2","volume":"10","author":"G Cullot","year":"2019","unstructured":"Cullot G, Boutin J, Toutain J, Prat F, Pennamen P, Rooryck C, et al. Crispr-cas9 genome editing induces megabase-scale chromosomal truncations. Nat Commun. 2019;10:1136.","journal-title":"Nat Commun"},{"key":"336_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.omtm.2018.06.006","volume":"10","author":"VL Simhadri","year":"2018","unstructured":"Simhadri VL, McGill J, McMahon S, Wang J, Jiang H, Sauna ZE. Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population. Mol Ther Methods Clin Dev. 2018;10:105\u201312.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"336_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26830-7","volume":"12","author":"CH Hakim","year":"2021","unstructured":"Hakim CH, Kumar SRP, Perez-Lopez DO, Wasala NB, Zhang D, Yue Y, et al. Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models. Nat Commun. 2021;12:6769.","journal-title":"Nat Commun"},{"key":"336_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14957-y","volume":"11","author":"P Gee","year":"2020","unstructured":"Gee P, Lung MSY, Okuzaki Y, Sasakawa N, Iguchi T, Makita Y, et al. Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat Commun. 2020;11:1334.","journal-title":"Nat Commun"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00336-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00336-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00336-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:05:40Z","timestamp":1671062740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00336-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1038\/s41434-022-00336-3","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"8 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}